Integration of HIV and Tuberculosis Services

The dual epidemics of HIV and tuberculosis (TB) present intertwined clinical and public health challenges, particularly in regions of high coinfection. Integration of HIV and TB services seeks to co-ordinate prevention, diagnosis, treatment and support within a unified delivery framework. By co-locating screening and treatment for both conditions—often described as a one-stop clinic model—health systems can accelerate case finding, reduce patient attrition and optimise use of human and material resources. Integrated services encourage early antiretroviral therapy initiation alongside prompt TB care, improving clinical outcomes and lowering mortality. They also foster stronger adherence through combined counselling and community outreach, while mitigating the stigma associated with single-disease programmes. Effective integration demands alignment of funding streams, harmonisation of clinical guidelines and investment in workforce training. Despite these hurdles, integrated HIV–TB models are central to universal health coverage and are endorsed by global health authorities as essential to achieving Sustainable Development Goal targets for ending both epidemics.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Integration of HIV and Tuberculosis Services publication trend

The graph below shows the total number of articles in integration of hiv and tuberculosis services across all publications each year (not limited to Nature Index journals).

Technical terms

Universal Testing and Treatment (UTT): A public health strategy offering HIV testing to all individuals in a defined population and initiating antiretroviral therapy immediately for those diagnosed positive.

Integrated Service Delivery: The systematic coordination of multiple health services—here HIV and TB—within a single organisational and clinical framework to improve efficiency and patient outcomes.

One-stop Clinic: A care model in which patients receive comprehensive related services (such as diagnosis, treatment and counselling for HIV and TB) at the same facility in one visit.

Antiretroviral Therapy (ART): The combination drug regimen used to suppress HIV replication, improve immune function and prevent opportunistic infections including TB.

References

1. Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial. PLOS Medicine (2024).
2. Developing a Model for Integrating of Tuberculosis, Human Immunodeficiency Virus and Primary Healthcare Services in Oliver Reginald (O.R) Tambo District, Eastern Cape, South Africa. International Journal of Environmental Research and Public Health (2023).
3. What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?. F1000Research (2018).